Newsroom

Sorted by: Latest

-

Resumen: Biocytogen completa su salida a bolsa en el mercado STAR, convirtiéndose en la primera empresa innovadora farmacéutica global «H+A»

PEKÍN, SHANGHÁI Y HONG KONG--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. («Biocytogen», SSE: 688796; HKEX: 02315), empresa biotecnológica global dedicada a la investigación para crear fármacos innovadores, acaba de anunciar su salida a bolsa en el mercado STAR de la Bolsa de Shanghái. Esto se produce tras empezar a cotizar en la Bolsa de Hong Kong en septiembre de 2022 y supone un importante hito para Biocytogen como la primera empresa farmacéutica innovadora global con dobl...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 09.12.2025 LANDXN.LN IE000RN036E0 28,035.00 USD 561,436.78 20.026  ...
-

New Director Representing the Municipal Water District of Orange County Joins Metropolitan board

LOS ANGELES--(BUSINESS WIRE)--Policy professor and water consultant Randall Crane was seated Tuesday as the Municipal Water District of Orange County’s newest representative on the board of directors of the Metropolitan Water District of Southern California. Crane is a professor emeritus at the UCLA Luskin School of Public Affairs, where he studied water governance, infrastructure planning, transportation, and the economic development challenges of cities. Through his career, he has advised the...
-

Propeller and The Legends for Charity® Dinner Invite Fans to Enter to Win Tickets to Super Bowl LX, Benefiting St. Jude Children's Research Hospital

MEMPHIS, Tenn.--(BUSINESS WIRE)--Propeller, the digital platform that connects fans to causes through culture, community and experiences, today announced an opportunity to take action to be entered to win two tickets to Super Bowl LX with proceeds benefitting the lifesaving mission of St. Jude Children’s Research Hospital®: Finding cures. Saving children.® The opportunity is offered in partnership with the Legends for Charity® Dinner, which presents The Pat Summerall Award annually during Super...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Innovative Transaction & Process UCITS ETF 09.12.2025 LEGR LN IE00BF5DXP42 1,025,002.00 USD 48,864,788.57 47.673  ...
-

Biocytogen finalise son introduction en bourse sur le marché STAR et devient le premier innovateur mondial dans le domaine des médicaments « H+A »

PÉKIN, SHANGHAI et HONG KONG--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (« Biocytogen », SSE : 688796 ; HKEX : 02315), une société internationale de biotechnologie spécialisée dans la découverte de médicaments innovants, a annoncé aujourd’hui son introduction réussie sur le marché STAR de la Bourse de Shanghai. Ce lancement fait suite à celui de la société à la Bourse de Hong Kong en septembre 2022 et marque une étape importante dans l’établissement de Biocytogen en tant q...
-

NYSE: KLAR Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Klarna Group plc (NYSE: KLAR) Investors with Significant Losses to Contact the Firm

RADNOR, Pa.--(BUSINESS WIRE)--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Klarna Group plc (NYSE: KLAR) (“Klarna”). Klarna provides payment, advertising, and digital retail banking solutions to consumers and merchants. On or around September 10, 2025, Klarna conducted its IPO at $40.00 per share. On November 18, 2025, Klarna issued its third quarter 2025 financial r...
-

Samenvatting: Biocytogen rondt beursgang op STAR Market af en wordt de eerste 'H+A'-innovatieve farmaceutische onderneming met wereldwijde activiteiten

BEIJING & SHANGHAI & HONG KONG--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen,” SSE: 688796; HKEX: 02315), een wereldwijd biotechnologiebedrijf dat actief is op het gebied van innovatieve geneesmiddelenontwikkeling, heeft vandaag bekendgemaakt dat het met succes is genoteerd aan de STAR Market van de Shanghai Stock Exchange. Dit volgt op de notering van het bedrijf aan de Hong Kong Stock Exchange in september 2022 en markeert een belangrijke mijlpaal in de positio...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NASDAQ Clean Edge Green Energy UCITS ETF 09.12.2025 QCLN.LN IE00BDBRT036 525,002.00 USD 9,271,149.97 17.659  ...
-

KBRA Assigns Preliminary Ratings to Willis Engine Structured Trust IX

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to the Series A Notes issued by Willis Engine Structured Trust IX (WEST IX), an aviation ABS transaction. WEST IX represents the tenth aviation ABS transaction serviced and sponsored by Willis Lease Finance Corporation (the Company ). The Company is comprised of 495 individuals operating out of 10 offices with headquarters in Coconut Creek, Florida. As of September 30, 2025, the Company owned 354 aircraft engines and 20 aircraft. A por...